Shaw, Elana RElana RShawRosen, Lindsey BLindsey BRosenARISTINE CHENGDobbs, KerryKerryDobbsDelmonte, Ottavia MOttavia MDelmonteFerré, Elise M NElise M NFerréSchmitt, Monica MMonica MSchmittImberti, LuisaLuisaImbertiQuaresima, VirginiaVirginiaQuaresimaLionakis, Michail SMichail SLionakisNotarangelo, Luigi DLuigi DNotarangeloHolland, Steven MSteven MHollandSu, Helen CHelen CSu2022-10-282022-10-282022-08-241058-4838https://scholars.lib.ntu.edu.tw/handle/123456789/624136Binding levels and neutralization activity of anti-type 1 interferon autoantibodies peaked during acute coronavirus disease 2019 and markedly decreased thereafter. Most patients maintained some ability to neutralize type 1 interferon into convalescence despite lower levels of binding immunoglobulin G. Identifying these autoantibodies in healthy individuals before the development of critical viral disease may be challenging.enCOVID-19; IFN-α; IFN-ω; autoantibodies; convalescence[SDGs]SDG3journal article10.1093/cid/ciab1002348750332-s2.0-85136644226WOS:000789391000001https://api.elsevier.com/content/abstract/scopus_id/85136644226